OBJECTIVE: To review evidence on the workplace prevalence and correlates of major depressive episodes, with a particular focus on the National Comorbidity Survey Replication, the most recent national survey to focus on these issues. METHOD: Nationally representative survey of Diagnostic and Statistical Manual, 4th Revision Mental Disorders. RESULTS: A total of 6.4% of employed National Comorbidity Survey Replication respondents had 12-month major depressive disorder. An additional 1.1% had major depressive episodes due to bipolar disorder or mania-hypomania. Only about half of depressed workers received treatment. Fewer than half of treated workers received care consistent with published treatment guidelines. CONCLUSIONS: Depression disease management programs can have a positive return-on-investment from the employer perspective, but only when they are based on best practices. Given the generally low depression treatment quality documented here, treatment quality guarantees are needed before expanding workplace depression screening, outreach, and treatment programs.
OBJECTIVE: To review evidence on the workplace prevalence and correlates of major depressive episodes, with a particular focus on the National Comorbidity Survey Replication, the most recent national survey to focus on these issues. METHOD: Nationally representative survey of Diagnostic and Statistical Manual, 4th Revision Mental Disorders. RESULTS: A total of 6.4% of employed National Comorbidity Survey Replication respondents had 12-month major depressive disorder. An additional 1.1% had major depressive episodes due to bipolar disorder or mania-hypomania. Only about half of depressed workers received treatment. Fewer than half of treated workers received care consistent with published treatment guidelines. CONCLUSIONS:Depression disease management programs can have a positive return-on-investment from the employer perspective, but only when they are based on best practices. Given the generally low depression treatment quality documented here, treatment quality guarantees are needed before expanding workplace depression screening, outreach, and treatment programs.
Authors: Laura Andrade; Jorge J Caraveo-Anduaga; Patricia Berglund; Rob V Bijl; Ron De Graaf; Wilma Vollebergh; Eva Dragomirecka; Robert Kohn; Martin Keller; Ronald C Kessler; Norito Kawakami; Cengiz Kiliç; David Offord; T Bedirhan Ustun; Hans-Ulrich Wittchen Journal: Int J Methods Psychiatr Res Date: 2003 Impact factor: 4.035
Authors: Joseph R Calabrese; Robert M A Hirschfeld; Michael Reed; Marilyn A Davies; Mark A Frye; Paul E Keck; Lydia Lewis; Susan L McElroy; James P McNulty; Karen D Wagner Journal: J Clin Psychiatry Date: 2003-04 Impact factor: 4.384
Authors: Harold Alan Pincus; Lin Hough; Jeanie Knox Houtsinger; Bruce L Rollman; Richard G Frank Journal: Int J Methods Psychiatr Res Date: 2003 Impact factor: 4.035
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: Ramin Mojtabai; Elizabeth A Stuart; Irving Hwang; Ryoko Susukida; William W Eaton; Nancy Sampson; Ronald C Kessler Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2015-07-27 Impact factor: 4.328
Authors: Waleed Salah Eldin; Jon Mark Hirshon; Gordon S Smith; Abdel-Aziz Mohamad Kamal; Aisha Abou-El-Fetouh; Maged El-Setouhy Journal: BMJ Open Date: 2012-11-27 Impact factor: 2.692
Authors: S E Lagerveld; U Bültmann; R L Franche; F J H van Dijk; M C Vlasveld; C M van der Feltz-Cornelis; D J Bruinvels; J J J M Huijs; R W B Blonk; J J L van der Klink; K Nieuwenhuijsen Journal: J Occup Rehabil Date: 2010-09